Raymond James Financial Services Advisors Inc. Boosts Stock Holdings in Apyx Medical Co. (NASDAQ:APYX)

Raymond James Financial Services Advisors Inc. boosted its stake in shares of Apyx Medical Co. (NASDAQ:APYX) by 44.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 608,628 shares of the company’s stock after acquiring an additional 187,350 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Apyx Medical were worth $1,595,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. Rhumbline Advisers raised its stake in shares of Apyx Medical by 16.1% in the 1st quarter. Rhumbline Advisers now owns 27,228 shares of the company’s stock valued at $178,000 after acquiring an additional 3,769 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Apyx Medical by 33.5% in the 2nd quarter. Goldman Sachs Group Inc. now owns 22,241 shares of the company’s stock valued at $130,000 after acquiring an additional 5,580 shares during the period. MetLife Investment Management LLC raised its stake in shares of Apyx Medical by 57.0% in the 1st quarter. MetLife Investment Management LLC now owns 18,314 shares of the company’s stock valued at $120,000 after acquiring an additional 6,649 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of Apyx Medical by 3,565.1% in the 3rd quarter. Tower Research Capital LLC TRC now owns 7,147 shares of the company’s stock valued at $32,000 after acquiring an additional 6,952 shares during the period. Finally, Advisor Group Holdings Inc. raised its stake in shares of Apyx Medical by 94.1% in the 4th quarter. Advisor Group Holdings Inc. now owns 19,594 shares of the company’s stock valued at $46,000 after acquiring an additional 9,498 shares during the period. Hedge funds and other institutional investors own 55.33% of the company’s stock.

Apyx Medical Stock Performance

Shares of APYX stock opened at $1.55 on Friday. The company’s fifty day simple moving average is $1.92 and its 200-day simple moving average is $2.26. Apyx Medical Co. has a 52 week low of $1.21 and a 52 week high of $7.97. The company has a current ratio of 5.52, a quick ratio of 4.74 and a debt-to-equity ratio of 1.23. The company has a market cap of $53.69 million, a PE ratio of -2.87 and a beta of 1.09.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.